
Quotient Limited QTNT
Quartalsbericht 2023-Q3
hinzugefügt 23.05.2026
Land |
|
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
102 M |
Marktkapitalisierung |
$ 1.1 M |
EBITDA (LTM) |
$ -115 M |
P/E (LTM) |
- |
P/S (LTM) |
0.03 |
EPS (LTM) |
-17.44 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Agilent Technologies
A
|
$ 117.49 | 2.11 % | $ 35.7 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 133.59 | -0.5 % | $ 6.25 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 8.81 | -3.29 % | $ 11.7 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 20.18 | 2.49 % | $ 585 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 17.68 | 0.03 % | $ 544 M | Nasdaq Global Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 121.14 | 1.08 % | $ 15.2 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 21.65 | 0.51 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
ICON Public Limited Company
ICLR
|
$ 114.27 | 0.37 % | $ 9.43 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | -1.1 % | $ 7.96 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 145.45 | 0.15 % | $ 23.1 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 98.62 | -1.44 % | $ 6.66 B | Nasdaq Global Select Market,SPB | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 161.57 | 3.21 % | $ 8.01 B | NYSE,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 115.21 | 1.26 % | $ 23 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
NeoGenomics
NEO
|
$ 9.31 | 0.43 % | $ 1.19 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 427.31 | -0.42 % | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.94 | -0.53 % | $ 424 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 199.2 | -0.85 % | $ 19.6 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.87 | 0.52 % | $ 358 M | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 9.01 | 0.73 % | $ 804 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.87 | -0.32 % | $ 25.5 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 6.38 | -0.85 % | $ 266 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.47 | - | $ 5.67 M | Nasdaq Capital Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 66.0 | 1.74 % | $ 3.95 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 263.33 | 1.9 % | $ 21.9 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 455.11 | 1.53 % | $ 172 B | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 345.15 | 1.91 % | $ 20.6 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.64 | -1.87 % | $ 230 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.29 | 1.59 % | $ 2.01 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 195.77 | 1.48 % | $ 21.7 B | NYSE,SPB |